These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21470140)

  • 1. Promises of apoptosis-inducing peptides in cancer therapeutics.
    Barras D; Widmann C
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1153-65. PubMed ID: 21470140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis-modulating agents in combination with radiotherapy-current status and outlook.
    Belka C; Jendrossek V; Pruschy M; Vink S; Verheij M; Budach W
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):542-54. PubMed ID: 14751526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-apoptotic peptides-based cancer therapies: challenges and strategies to enhance therapeutic efficacy.
    Min KA; Maharjan P; Ham S; Shin MC
    Arch Pharm Res; 2018 Jun; 41(6):594-616. PubMed ID: 29804279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic modulation of apoptosis: targeting the BCL-2 family at the interface of the mitochondrial membrane.
    Nemec KN; Khaled AR
    Yonsei Med J; 2008 Oct; 49(5):689-97. PubMed ID: 18972587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
    Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
    BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid induces apoptosis of human malignant cancer cells.
    Li MY; Liang NC; Chen GG
    Curr Drug Targets; 2012 Dec; 13(14):1730-7. PubMed ID: 23140284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Serum Albumin and the p53-Derived Peptide Fusion Protein Promotes Cytotoxicity Irrespective of p53 Status in Cancer Cells.
    Roscoe I; Parker M; Dong D; Li X; Li Z
    Mol Pharm; 2018 Nov; 15(11):5046-5057. PubMed ID: 30226785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.
    Raucher D; Moktan S; Massodi I; Bidwell GL
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1049-64. PubMed ID: 19743895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy.
    Shteinfer-Kuzmine A; Amsalem Z; Arif T; Zooravlov A; Shoshan-Barmatz V
    Mol Oncol; 2018 Jun; 12(7):1077-1103. PubMed ID: 29698587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells.
    Wang JL; Liu D; Zhang ZJ; Shan S; Han X; Srinivasula SM; Croce CM; Alnemri ES; Huang Z
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7124-9. PubMed ID: 10860979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer therapeutics: Targeting the apoptotic pathway.
    Khan KH; Blanco-Codesido M; Molife LR
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting malignant mitochondria with therapeutic peptides.
    Constance JE; Lim CS
    Ther Deliv; 2012 Aug; 3(8):961-79. PubMed ID: 22946430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To Prime, or Not to Prime: That Is the Question.
    Potter DS; Letai A
    Cold Spring Harb Symp Quant Biol; 2016; 81():131-140. PubMed ID: 27811212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
    Kostanová-Poliaková D; Sabová L
    Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies.
    Pistritto G; Trisciuoglio D; Ceci C; Garufi A; D'Orazi G
    Aging (Albany NY); 2016 Apr; 8(4):603-19. PubMed ID: 27019364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.